(Q43634452)

25 November 2017

Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma (English)

1 reference

Erb-b2 receptor tyrosine kinase 2

25 November 2017

1 reference

1 reference

8

Mario A Hermsen

1 reference

25 November 2017

Fernando López

1

1 reference

25 November 2017

José Luis Llorente

2

1 reference

25 November 2017

Carlos Martín Oviedo

3

1 reference

25 November 2017

Blanca Vivanco

4

1 reference

25 November 2017

César Álvarez Marcos

5

1 reference

25 November 2017

Cristina García-Inclán

6

1 reference

25 November 2017

Bartolomé Scola

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

25 August 2011

1 reference

25 November 2017

1 reference

25 November 2017

118

1 reference

25 November 2017

7

1 reference

25 November 2017

1818-1826

1 reference

Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review.

25 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Results of multimodality therapy for squamous cell carcinoma of maxillary sinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Sinonasal cancer, occupation, and tobacco smoking in European women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Sinonasal malignancy: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

EGFR-targeting monoclonal antibodies in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Epidermal growth factor receptor biology in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Clinical significance of the epidermal growth factor receptor gene in m squamous cell carcinomas of the nasal cavities and paranasal sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

ErbB receptors in the biology and pathology of the aerodigestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Oral cancer progression and c-erbB-2/neu proto-oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Lymph node metastasis in maxillary sinus carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Mutations of the BRAF gene in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Genomic profiling of sinonasal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Amplification of ERBB oncogenes in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative Surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Prognostic factors of maxillary sinus malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Expression of c-erbB receptors and ligands in human nasal epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Integration of EGFR inhibitors with radiochemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26451

7 January 2021

Identifiers

DOI

10.1002/CNCR.26451

1 reference

25 November 2017

1 reference